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ABSTRACT 
BACKGROUND AND OBJECTIVES 
Hypertension is a leading cause for Non Communicable diseases.The 
aim was to study the association of dietary sodium and potassium as estimated 
from the urinary excretion of these cations with blood pressure. 
METHODS  
Institutional Human Ethical committee clearance was obtained. After 
taking an informed consent, 260 patients were enrolled in the study which 
included 130 hypertensives and 130 non-hypertensives. All the subjects were in 
the age group of 30 to 79 years. A random clean catch  urine sample was 
collected for estimation of sodium and potassium and routine blood tests for 
hypertension workup were done.The 24 hour urine sodium and potassium was 
estimated from the spot samples using the Kawasaki formula. Data collected 
was analysed by SPSS  version 20.1 
RESULTS  
The average systolic BP among the non-hypertensives was 117.6 ± 
9.05 and average diastolic blood pressure was 72.15 ± 6.93. The average 
systolic blood pressure among the hypertensives was 143.3 ± 15.1 and 
average diastolic blood pressure was 90.92 ± 7.41. The average urinary 
sodium excretion in 24 hrs among non- hypertensives was 5131.49 ± 1013.65 
mg/d and among hypertensives was 6343.05 ± 2362.73 mg/d. The average 
urinary potassium excretion in 24 hrs among the non-hypertensives was 
2100.72 ± 476.47 mg/d and among hypertensives was 2291.61 ± 534.93 
mg/d. The mean ratio of 24 hr urinary excretion of sodium to 24 hr urinary 
excretion of potassium was 2.51 ± 0.55 in the non-hypertensive group and 
2.72 ± 0.59 mg/d in the hypertensive group. 
 There was a positive correlation between the daily urinary sodium, 
urine potassium and 24 hr urine sodium-potassium ratio with systolic and 
diastolic BP among the hypertensives. There was no significant correlation 
among the non-hypertensives. 
CONCLUSIONS 
 In a developing country like India to control the menace of 
hypertension, modifiable risk factors like dietary salt intake need to be 
controlled. Government policy makers and NGOs should work together to 
conduct salt reduction programmes to create awareness among the public and 
avert premature death and disability. 
Key words: Hypertension, Urinary sodium, Urinary potassium 
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INTRODUCTION 
With the changing life style and increasing daily stress the incidence of 
hypertension is on the rise. Hypertension is considered as the number one silent 
killer among all the diseases worldwide. Hypertension remains to impose 
burden on the society in terms of an enormous health and economic 
expenditure although there are wide variety of anti-hypertensives to combat  it. 
It is an interesting fact that not only is hypertension on the rise but also the 
prevalence of uncontrolled hypertension is continuously rising all over the 
world. This points to the fact that there is an important need to understand the 
underlying mechanism’s of hypertension, more importantly the modifiable risk 
factors and intervenable risk factors.1 
The World Health Statistics in the year 2012 estimated that there were 
fifty seven million global deaths in 2008, sixty three percent of them were due 
to diseases that are non-communicable diseases. The largest proportion of non-
communicable disease deaths is caused by cardiovascular diseases (48%). In 
terms of attributable deaths, elevated blood pressure level plays a significant 
role as a behavioral and physiological risk factor for 13% of  the global deaths. 
Hypertension is the fourth contributor to premature death in developed 
countries and the seventh in developing countries.2,3 
Hypertension in adults ≥ 18 years  is defined as systolic blood pressure 
(SBP) of ≥140 mm Hg  and/ or diastolic blood pressure (DBP) of  ≥90 mm Hg 
or any level of blood pressure in patients taking medication for hypertension.1,4  
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            Untreated or poorly controlled hypertension leads to target-organ 
damage (TOD) and its   serious vascular complications events like hypertensive 
nephropathy, hypertensive cardio-myopathy, heart failure, myocardial 
infarction, cerebro-vascular accident, hypertensive retinopathy, atherosclerosis, 
aneurysms and cardiovascular disease which drastically decreases the life 
expectancy, quality and productivity of the individual. 
       Inspite of all these well-known complications of uncontrolled 
hypertension it remains inadequately detected and treated. This is mainly due to 
the asymptomatic nature of the disease, especially during the initial years while 
there is an ongoing damage to multiple organ systems. Hence cardiovascular 
risk and its complications remains high among hypertensive patients. 
Studies have demonstrated that there exists a continuous relationship between 
the blood pressure levels and the probable risk of developing complications. 
The risk of developing cardiovascular complications starts at 115/75 mmHg 
and is seen to double with each increment of 20/10 mm Hg throughout the 
blood pressure range.5-7 For persons over the age of 50 years, Systolic blood 
pressure is seen to be a more important risk factor of CVD than Diastolic blood 
pressure  and moreover Systolic Bp is more difficult to control than Diastolic 
Bp in this  population. Recent studies point to the fact that the risk of 
developing cardiovascular events in Asian Indians is higher at  relatively lower 
levels of blood pressure when compared to the Western population. 
Multiple international authorities have come forth with various 
definitions of hypertension which are all arbitrary. The term ‘Pre-hypertension’ 
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coined by the Joint National Committee VII guidelines includes a wide range 
of BP from normal to high normal taking into fact that there is a strong 
evidence that this high normal population  needs to be treated sometimes, 
especially in the presence of co- morbidities like diabetes mellitus or a  family 
history of hypertension.4,8  
A review of epidemiological studies in India suggests that the 
prevalence of hypertension has increased from 2% to 25% among the urban 
population and from 2% to 15% among the rural population in the last six 
decades. In a meta-analysis of multiple cardiovascular epidemiological studies 
carried out in our country, it was seen that prevalence rates of coronary artery 
disease and stroke have raised more than thrice in the Indian population. In the 
INTERHEART and INTERSTROKE study, hypertension accounted for 17.9% 
and 34.6% of population attributable risk of various cardiovascular risk factors 
for coronary artery disease and stroke respectively. According to the Indian 
Ministry of Health and Family Welfare, the overall prevalence of hypertension 
in India by 2020 will be 159.46/1000 population.9,10 
Multiple factors might have contributed to this increasing trend, 
attributable to various indicators of economic progress such as increase in the 
life expectancy, urbanization and its attendant lifestyle changes including 
increase in salt intake in the form of tinned foods and cola and the overall 
epidemiologic transition. The prevalence of hypertension has seen to increase 
with age among all populations. There is a marked increase in the prevalence of 
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diabetes, dyslipidemia, metabolic syndrome  and obesity while that of smoking 
has declined..10-12 
In a developing country like India hypertension awareness, treatment 
and control status is low, with only half of the urban and a quarter of the rural 
hypertensives actually being even aware that they have the disease. Inspite of 
all the awareness programmes being conducted by the Government it is seen 
that only one in five persons is actually on treatment among which less than 5% 
have their blood pressure under control. With more than enough evidence 
showing the deleterious effects of a sustained uncontrolled blood pressure on 
the population, more aggressive preventive measures are required so as to 
reduce obesity, increase the physical activity, decrease the salt intake of the 
population and a collective effort to promote awareness about hypertension and 
its other related risk behaviours. 
Effective population-based interventions are necessary to control the 
global burden of cardiovascular disease. Reducing dietary salt intake has 
emerged as a primary goal, with many guidelines including the World Heart 
Organization (WHO) in 2003, recommending that the adult population ingest 
<2.0 g/day of sodium (which corresponds to 5 g of salt/day), based on  
epidemiological studies which indicated a linear association between increasing 
levels of sodium intake and cardiovascular events13 and clinical trials that 
showed that a lower level of dietary sodium intake was associated with 
significant reduction in blood pressure.14-16 
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Since then, however, there have been a number of clinical trials and 
studies that have questioned whether this recommendation for dietary sodium 
intake is optimal, with some recent prospective cohort studies indicating that a 
sodium intake of under 3 g/day ( the current guidelines recommendation) may 
be actually deleterious and  associated with an increased risk of cardiovascular 
death.17-20 
These newer studies, and the fact that there are no definitive randomized 
controlled trials which show that reducing dietary sodium intake to low levels 
will reduce cardiovascular morbidity and mortality, have re-ignited the 
controversy surrounding the optimal target for sodium intake among the 
scientific fraternity. Since 1980s many research’s have been published 
regarding the association between dietary sodium intake and blood pressure 
and cardiovascular disease and till date there are very few areas in CVD 
prevention that evoke more diverse opinions. 
Diet being a modifiable factor plays a very important role in the etio-
pathogenesis and the treatment of hypertension. The dietary factors responsible 
for hypertension revolve around the electrolytes sodium and potassium. Hence 
I conducted the present study entitled   “Association of dietary sodium and 
potassium with blood pressure in a tertiary care centre” to better understand the 
association of dietary intake of sodium and potassium with blood pressure. 
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AIMS AND OBJECTIVES 
 
 To study the association of dietary intake of sodium and potassium as estimated 
from the urinary excretion of these cations with blood pressure. 
● To study factors associated with dietary intake of sodium and potassium in the 
hypertensive  group and normal population. 
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HYPOTHESIS AND SCIENTIFIC JUSTIFICATION 
HYPOTHESIS 
The alternate hypothesis states that there is a statistically significant 
association between dietary intake of sodium and potassium with blood 
pressure among the hypertensives. 
SCIENTIFIC JUSTIFICATION 
In this era of modern medicine, Non-Communicable Diseases (NCD) form the 
major cause of morbidity and mortality. The largest proportion of NCD deaths 
is caused by cardiovascular diseases. Over the years, epidemiological studies 
and clinical trials have shown a continuous linear relationship between high 
sodium intake and the risk of cardiovascular disease. These results are yet 
insufficient to conclude whether low sodium intake is associated with an 
increased or reduced risk of cardiovascular disease in the general population. 
Recently, few studies have also shown that a low salt intake may be 
associated with adverse health effects in some subgroups, including some 
patients with heart failure or other forms of cardiovascular disease, diabetes, or 
chronic kidney disease. Thus, there are inconsistencies whether a low sodium 
diet decreases the cardiovascular risk among the normal population and 
hypertensives or in the contrary is actually deleterious. 
Hypothesis 
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Then, there is the concept of salt sensitivity wherein blood pressure of 
some members of the population (salt-sensitive SS) exhibit changes parallel to 
changes in salt intake whereas the salt resistant (SR) ones do not. 
The association of dietary sodium and potassium with blood pressure is thus a 
very interesting and controversial topic. There are few studies from Chennai 
regarding the subject. The dietary intake of sodium and potassium and its 
association with blood pressure and other parameters among the population 
visiting our tertiary care centre SMIMS, Kulasekharam located in South Tamil 
Nadu would make a good study. 
In this dissertation, I have proposed to estimate the dietary intake of sodium 
and potassium from the urinary excretion of these cations and compare it with 
the blood pressure of normotensives and hypertensives . 
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REVIEW OF LITERATURE 
EPIDEMOLOGICAL TRENDS IN HYPERTENSION  
Definitions  
Hypertension as per the World Health Organization  is defined as “ a rise in 
blood pressure ( Systolic above 140 and Diastolic above 90 mm Hg) or taking 
antihypertensive medication.”13 
Blood pressure is defined as a continuous variable with no absolutely dividing 
line between  normal and abnormal values. The best operational definition is 
“the level at which the benefits (minus the risks & costs) of action exceeds the 
risks and costs (minus benefits) of inaction.” 22  
The definition of hypertension for home & ambulatory blood pressure 
monitoring (ABPM)  is different: 44 
Mean 24-hr ABPM SBP ≥130 mm Hg or DBP ≥80 mm Hg or 
Mean awake SBP ≥135 mmHg and /or DBP≥85 mm Hg  
EPIDEMIOLOGY OF HYPERTENSION 
 It has been foretold that the global prevalence of hypertension would rise in 
the twenty years by more than two fold from around 26% in 2005 to 60% by 
2025. 24 
Studies from various countries show an increasing prevalence of hypertension, 
the possibility being the fact that the changing lifestyle pattern including 
dietary habits, urbanisation, the aging population, increasing body mass index, 
stress and sedentary lifestyle all which lead to the development of  
hypertension. 25-26 
Review of Literature 
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WORLD HEALTH ORGANIZATION CLASSIFICATION OF 
HYPERTENSION  
The WHO/ISH blood pressure classification includes 3 grades of hypertension. 
Each stage of hypertension is characterized by the presence or absence of 
markers of hypertensive cardiovascular disease and the evidence of target 
organ damage irrespective  of the blood pressure level. 
 
 
FIGURE 01 : The WHO/ISH blood pressure classification 
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TOD – Target Organ Damage      ACC - Accompanying Clinical 
Conditions 
 
FIGURE- 02 :  CV risk stratification according to BP, other risk factors 
and disease history 
 
The ESH-ESC guidelines recommend a target bp of ˂ 140/90 mmHg for 
patients with uncomplicated hypertension as this is associated with average CV 
risk according to the Framingham study. 48 
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FIGURE--03 : ASH Writing Group definition and classification of hypertension  
 
The Amercan Society for Hypertension in the article Dietary Approaches to 
lower Blood pressure states that the risk factors for elevated blood pressure 
include increased salt intake, a low potassium intake, overweight, alcohol 
abuse, and sub-optimal dietary patterns. The efforts to decrease blood pressure 
should be carried out not only in the hypertensives but also the non-
hypertensives as studies have shown that dietary and lifestyle modifications 
prevent and delay if not stop the occurrence of hypertension. 49 
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      FIGURE 04: JNC VII1 Classification of Hypertension 44 
 
 
    TABLE 01 : JNC VIII Target BP Recommendation 44 
Normal 
Pre ‐ hypertensive   
Grade I hypertension 
Grade II 
hypertension 
• < 120 mmHg‐SBP 
• < 80 mmHg‐DSBP  
• 120 ‐ 139 mmHg‐SBP 
• 80 ‐ 89 mmHg‐DSBP 
• 140 ‐ 159 mmHg ‐SBP 
• 90 ‐ 99 mmHg D‐SBP 
• > 160 mmHg‐SBP 
•  > 100 mmHg‐DSBP 
PATIENT 
SUBGROUP 
TARGET SBP 
(mm Hg) 
TARGET DBP 
(mm Hg) 
≥ 60 YEARS ˂ 150 ˂ 90 
˂ 60 YEARS ˂ 140 ˂ 90 
˃ 18 YEARS 
WITH CKD 
˂ 140 ˂ 90 
˃ 18 YEARS 
WITH DM 
˂ 140 ˂ 90 
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   FIGURE 05: Comparison of recent guideline statements 
 
 *        ADA  ≤  140/80 mm Hg 
**       CDA  ˂  130/80 mm Hg 
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The “Rule of Halves” 
Hypertension remains an “iceberg” disease, with a significant 
percentage of cases being undetected. In the early 1970's studies showed that 
only half of the hypertensive population in developed countries were aware of 
the condition. Among them, only about half of them were under treatment, and 
only half of those being treated had optimally controlled blood pressure. This 
came to be known as the “rule of halves” and it is the present scenario in the 
developing countries. 
Natural history of untreated HT 
In untreated hypertensive cases as the age progresses there is a steady 
rise in the systolic blood pressure and a decline in the diastolic blood 
pressure .Thus in adults above the age of 50 years hypertension has a linear 
association with systolic blood pressure than with diastolic blood pressure. 
              Hypertension is a major risk factor for ischemic heart disease, 
strokes, cardiac failure, renal failure , decreased cognitive capabilities and 
all-cause mortality. The degree of decrease in blood pressure is associated in 
a linear fashion with risk reduction.5  
Pre hypertension  is related with double the risk of developing cardiovascular 
and cerebro vascular complications in women when compared to non 
hypertensive women. 
The prevalence of hypertension is higher in men until the age of 45 
years, in the age group of 45 years to 64 years the prevalence rate is equal 
and above the age of 64 years the prevalence is more in women. 1,2 
Review of Literature 
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The awareness regarding this silent pandemic and the treatment rates 
have substantially increased over the years. But data show that even among 
the known hypertensives about 50% do not have controlled blood pressures. 
44 This data is more significant among adults greater than 80 years. 
Risk Factors  
Risk factors for hypertension are as classified as modifiable and non-
modifiable risk factors  
Modifiable Lifestyle Risk Factors  
Cigarette Smoking  
Promotes s hypertension by the following factors 
 Reduced blood vessel compliance,  
 Increased fibrinogen levels,  
 Increased platelet aggregation,  
 Decreased high-density lipoprotein cholesterol levels, 
 Higher hematocrit  
Active cigarette smoking is the cause for around 18% of cerebrovascular 
accidents worldwide. Even passive cigarette smoking is shown to cause 
accelerated atherosclerosis. 
Alcohol Consumption  
Heavy alcohol consumption favors hypertension complications by  
 Elevating blood pressure,  
 Increasing the coagulability, 
 Predisposing to cardiac arrhythmias  
 Decreasing the cerebral blood flow  
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Sedentary life style  
Increased physical activity reduces the pro-athrogenic factors. A meta-
analysis of 23 studies that examined the relationship of physical activity with 
risk of developing stroke  noted that highly active subjects experienced a 27% 
lower risk of stroke or mortality when compared to low-active subjects. 
Diet 
Clinical trials have proven for years that adopting a low-risk diet 
accompanied by optimal weight reduction especially in the society would 
drastically decrease the burden of hypertension.  
JNC VIII recommends a limited sodium intake with adequate calcium 
and potassium in the daily diet. It also recommended the Dietary Approaches to 
Stop Hypertension (DASH) dietary model  with lower content of total fat and 
saturated fat and plenty of low-fat dairy products, fruits and nuts and 
vegetables. 
Non-Modfiable Risk Factors 
Age  
 Age is a very important non modifiable risk factor for development of 
hypertension. In a developing country like India, the complications of 
hypertension like stroke is seen to occur at a younger age than other countries. 
The average age of patients with stroke is 15 years younger than those in the 
developed countries. Around 20% of patients admitted with cerebro vascular 
accidents in India are aged less than 40 years. 10 
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Gender   
Males are more prone for development of hypertension than females. 
The prevalence of hypertension is higher in men until the age of 45 years and 
in the age group of 45 to 64 years, the prevalence rate is equal and above the 
age of 64 years the prevalence is more in women. 
Race and ethnicity 
Disparities in the level of blood pressure with race and ethnicity persist. 
The prevalence of hypertension is higher among the blacks than the whites and 
the blacks have been found to have higher average blood pressure 
measurements than the whites.7 This has also reflected in the incidence of 
complications with the blacks developing 1.8 times more strokes, 1.5 times 
more cardiovascular complications and 4.2 times more kidney disease when 
compared to the white population. 
Heredity 
Among individuals with a family history of hypertension, its incidence 
occurs 3.8 times more frequently before the age of 55. 
Genetic Factors 
Genes encoding for renin–angiotensin-aldosterone system with 
polymorphisms of angiotensinogen and angiotensin–converting enzyme are 
postulated to be associated with hypertension and the individual’s blood 
pressure response to dietary salt intake. The alpha-adducin gene is responsible 
for the higher renal tubular absorption of sodium and genetic variations are 
postulated to cause hypertension. 
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 THE ROLE OF SODIUM AND POTASSIUM IN HYPERTENSION  
Epidemiological Back Ground 
There is strong evidence that exists a relationship between blood 
pressure and dietary sodium and potassium intake, or the ratio of sodium to 
potassium intake.  
POTASSIUM 
Studies and trials show that populations with similar salt intake but 
different blood pressures had actually different potassium intake, with blacks 
excreting much less potassium than the white population. As high potassium 
diet tends to be more expensive, its intake may be a major factor in the 
epidemiologic differences of hypertension. The first strain of rats bred by 
Dahl for the trait of “salt sensitivity” demonstrated that incidence of salt-
induced hypertension was less when the potassium intake was high.23 
Years before in 1984, George Daniel Miller, et al in their research 
showed that there is a slight direct relationship between random urinary 
sodium concentration and blood pressure and this relationship is more 
significant for diastolic blood pressure. There exists an inverse relationship 
between urinary potassium concentration and blood pressure. Dietary sodium 
to potassium ratio is directly related to the mean blood pressure and is a 
strong predictor of blood pressure than either of sodium or potassium alone. 
The relationship between urinary sodium / urinary potassium and blood 
pressure varies with age, race, and sex. 
 
Review of Literature 
 
	 Page	20	
 
SODIUM  
The daily physiological requirement of sodium for the human body is 
around 180-230 mg/day. The cation sodium is the most common ion found 
in the extracellular fluid and it helps to maintain the blood volume, water 
balance, cell membrane potential, acid-base balance and nerve conduction. 
Sodium and its role in the maintenance of  blood pressure 
There is significant scientific data to suggest that there is a very strong 
positive association between daily dietary sodium intake and blood pressure 
within and between populations. Epidemiologic studies have shown that 
dietary sodium intake is directly proportional to cardiovascular morbidity 
and mortality and to the rise in blood pressure with aging. Various multi-
centric studies regarding the dietary salt intake and blood pressure have 
demonstrated its adverse prognostic outcome in both hypertensive and non-
hypertensive individuals. 
Renal Salt Excretion - the need for a proper balance  
More than 95% of the dietary salt taken is absorbed from the 
gastrointestinal tract and  the extra-renal loss of salt is insignificant, with 
normal sweating accounting usually for  0.058 g/d and other extra-renal 
losses for 0.002 to 0.18 g/d only. After absorption of the dietary salt from the 
gastrointestinal tract even a minimal increase in serum sodium concentration 
triggers thirst until the normal serum concentration is restored by taking 
more fluids. To elaborate, an excess salt intake of 8.3 g must be followed by 
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1-L increase in water intake to maintain the normal serum sodium 
concentration.  
 
         FIGURE 06: Adrenal-Renal axis 
Postulated mechanisms of salt-induced hypertension 
Since the 1980s, there have been many studies and trials carried out 
regarding dietary salt intake and blood pressure and yet till date this remains 
a controversial topic. There are many mechanisms which have been put forth 
to explain salt- induced hypertension.  
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Role of Kidneys 
Dahl, et al in  their scientific experiment with rats showed that when 
the kidneys of a rat with normal blood pressure is transplanted to another rat 
with high blood pressures the blood pressure of the recipient rat did not rise 
and conversely, when the kidneys from a rat with high blood pressure is 
transplanted to a rat with normal blood pressure, the blood pressure of the 
recipient rat was elevated. This same phenomenon was obsereved in human 
population. Adults who were initially known to have systemic hypertension 
after undergoing a renal transplant (for any cause of chronic kidney disease) 
from a donor with normal blood pressure, had significant fall in their mean 
blood pressure values. 
Role of extra cellular volume 
This is the oldest postulated mechanism for dietary sodium induced 
hypertension. It is said that the kidneys lose their ability to excrete sodium 
and hence leading to sodium retention which in turn retain water along with 
it. This in turn causes plasma volume expansion which initiates other 
compensatory mechanisms leading to increase in blood pressure which helps 
the kidneys to excrete sodium. 
Role of serum sodium 
Recent studies have shown that the daily salt intake causes changes in 
the serum sodium levels and hence is associated with variations in blood 
pressure. Many epidemiological studies have proven that there is a positive 
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association between serum sodium and blood pressure. However the 
hallmark Framingham Heart Study proved that there was no relation between 
the serum sodium levels and blood pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 07: Dietary sodium and its association with blood pressure 
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REVIEW OF RELATED STUDIES  
He FJ, Li J, Macgregor G, et al in 2013 did a cochrane based meta-
analysis which included 34 trials with 3230 participants. It concluded that 
even a minimal decrease in the dietary salt intake for 4 or more weeks caused 
significant fall in blood pressure in both hypertensives as well as non-
hypertensives, irrespective of sex and race. This study showed a positive 
correlation between the decrease in 24-h urinary sodium and the decrease in 
systolic BP, showing that the more the reduction in dietary salt intake, the 
greater is the decrease in systolic BP. 21 
  Njeri Karanja, Kristie J. Lancaster, et al did a randomized crossover 
trial among 354 adults with pre-hypertension or stage 1 hypertension in order 
to study the palatability and compliance of guideline recommendations 
among hypertensives. They found that the intermediate sodium level was 
slightly more acceptable than either the higher or lower level especially with 
the DASH diet. They also found the DASH diet was more acceptable than 
the control diet at all sodium levels. The study concluded that the lower 
sodium level-1200 mg/day (current recommendation) as the adequate intake 
and a goal to aim for, and the intermediate sodium level-2300 mg/day, which 
is the safe upper limit and well accepted by the participants, should be 
extrapolated to the population at risk for developing hypertension. 22 
 Andrew Mente, Martin J. O’Donnell, Sumathy Rangarajan, et al in 
2014 did a multi-centric trial based on the Prospective Urban Rural 
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Epidemiology (PURE) study which included 102,216 adults from 18 
different countries including India. In this study, the association of estimated 
dietary intake of sodium and potassium which was determined from 
measurements of urinary excretion of sodium and potassium, with blood 
pressure was found to be nonlinear and was most significant in persons on 
high-sodium diet, known hypertensives and elderly population. The 
Kawasaki formula was used to estimate the 24hr urinary excreted sodium 
and potassium which was used as a surrogate for the dietary intake of these 
salts. 23 
 Chien, Kuo-Liong, Hsiu-Ching, et al investigated the role of 24-h 
urinary sodium excretion and its association with hypertension risk among 
ethnic Chinese. In a prospective community-based cohort study conducted in 
Taiwan, 1520 middle-aged and elderly participants who were non-
hypertensive at baseline were enrolled and was found that high urinary 
sodium excretion was associated with the risk of developing hypertension. 
They concluded that urinary sodium excretion could be used as a marker of 
dietary sodium intake, and can be useful for the evaluation of hypertension 
risk among the Asian populations.24 
 Minoru Kawamura, Yuki Kusano, et al in 2005 conducted a study in 
Japan to determine the effectiveness of a Spot Urine Method (SUM) 
postulated by Kawasaki in evaluating daily salt intake in hypertensive 
patients taking oral antihypertensive drugs. They estimated the daily salt 
intake in 73 hypertensive patients by SUM and by a post food consumption 
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method (FCM) when they were at home, and also by SUM in the hospital 
with a fixed intake of 7 g of sodium chloride (NaCl). The mean dietary 
intake at admission in this population was 7-8 gm/day. The study concluded 
that SUM is a reliable method for evaluating daily salt intake in patients 
taking antihypertensive medication as well as in patients not on medication 
and that the Kawasaki formula derived dietary salt intake was significantly 
related to blood pressure even when applied to post prandial urine sample. 25 
Eberhard Ritz, Nadezda Koleganova,Grzegorz Piecha, et al in 2009 
conducted a study in Germany  regarding the role of dietary sodium  in the 
progression of Chronic Kideney Disease. They concluded that there was a 
close relationship between salt intake and the development of hypertension 
and cardiovascular events, as well as blood pressure−independent target 
organ damage including kidney disease. Increase in salt causes raised 
albuminuria in individuals without primary renal disease and increases the 
excretion of albumin in patients with pre-existing renal disease. It also stated 
that treatment with diuretics could not replace the effects of dietary salt 
restriction. 26 
 Radhika G, Sathya RM, Mohan V, et al in 2007 did a study among 
the urban population of South India regarding the dietary salt intake 
(CURES-53). This study concluded that intake of dietary salt in urban South 
Indian population is higher than the current WHO recommendation. An 
increased salt intake was significantly related with increased risk for 
hypertension. 27 
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 Deepa R, Premalatha G, Mohan V et al in 2003 conducted the 
Chennai Urban Population Study (CUPS), an epidemiological study with 
1262 participants in Chennai. The study stated that the prevalence of 
hypertension increased in the presence of other risk factors such as a raised 
BMI, diabetes, obesity, CAD, PVD, and waist-hip ratio, with the 
socioeconomic status of the individual playing a major role. 28 
Mohan S, Campbell NR, et al in 2009 evaluated the association 
between excessive dietary salt intake and the significance of a generalized 
population-based strategy to decrease the dietary salt and concluded that with 
the threat of  increasing cardiovascular disease all over the world, especially 
in low economic and developing countries, salt restriction is the most 
economic strategy to fight hypertension and its associated cardiovascular 
diseases. 29 
Fodor JG, Whitmore B, Leenen F, et al in 1999 in Canada provided 
recommendations regarding the effects of  salt intake on the prevention and 
control of hypertension in adults. Salt restriction for the population with 
normal blood pressure was discouraged. For hypertensives over the age of 44 
years, moderate restriction of the dietary intake of sodium 90-130 mmol/day 
(3-7 g of salt/day) was recommended. The dietary salt was recommended to 
be estimated by questionnaires. 30 
Burgess E, Lewanczuk R, Bolli P, Chockalingam A, et al in 1999 in 
Canada provided recommendations on the consumption of potassium, 
magnesium and calcium. They recommended a daily dietary potassium of 
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atleast 60 mmol, as it reduced the risk of cerebro vascular accidents. For non-
hypertensive people already receiving atleast 60 mmol of potassium in their 
daily diet supplements were not recommended for prevention of 
hypertension. In hypertensives already receiving daily dietary potassium of 
atleast 60 mmol, supplements were not recommended as a treatment. 31 
 He FJ, Mac Gregor GA, et al in 2009 made a meta-analysis and 
concluded that an increased daily salt intake directly increased the risk of 
strokes, left ventricular hypertrophy and kidney disease independent of its 
relation with blood pressure. 32 
Park J, Kwock CK, Yang YJ, et al in 2016 investigated the effect of 
sodium to potassium ratio on blood pressure and the prevalence of 
hypertension from the Korean National Health and Nutrition Examination 
Surveys between 2010 and 2014. Higher prevalence rates of hypertension 
were seen with higher sodium to potassium ratio. 33 
Cook NR, et al in 2008 did a meta-analysis of the association of salt 
intake with blood pressure and cardiovascular disease among the normal 
population. It concluded that even with a  small change in blood pressure, the 
cardiovascular disease risk came down by 25% even among the non-
hypertensive population. 34 
Huang F, Yu P, Yuan Y, Li Q, et al in 2016 did a study among 951 
hypertensive patients and the results suggested that there was a higher level 
of urinary sodium excretion in the hypertensive population and it was 
associated with renal and retinal damage. 35 
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Sun Yi, Lei Rensheng, Romaina Iqbal, et al in 2016 did a pooled 
analysis, which studied 133 118 individuals from 49 countries in four large 
prospective studies and estimated 24-h urinary sodium excretion and equated 
it to dietary sodium. High sodium intake was associated with an increased 
risk of cardiovascular events and death among the hypertensives but not in 
non-hypertensives. It also concluded that there were increased adverse 
cardiovascular events in normal population taking a low sodium diet. This 
study implied that measures to reduce the dietary sodium should be targeted 
to only those with hypertension. 36 
Hooper L, Bartlett C, Davey SG, et al in 2004 did a cochrane review 
in which there was a follow-up period of up to seven years. They put forth 
that rigorous measures to restrict sodium intake in the normal population is 
unwarranted as it produced only a meagre reduction in the blood pressure 
during long term follow up. 37 
M.J. O'Donnell, A. Mente, A. Smyth, S. Yusuf, et al in 2012 did a 
met-analysis of eight prospective cohort studies in which two reported a 
positive association, two reported no association, and four reported a 
negative association between the dietary salt intake and cardiovascular 
events. 38 
Suckling RJ, He FJ, Macgregor GA, et al did a meta analysis in 2010 
with thirteen studies which showed  a significant decrease in blood pressure 
with dietary salt restriction, almost equivalent to that of individuals on a 
single antihypertensive drug especially among the non-hypertensives. 39 
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Gary Taubes, et al in 1998 did a meta-analysis review which 
concluded that the apparent benefits of a restricted salt diet were actually 
biased. It commented that the term called “salt sensitivity” could explain the 
reason why the blood pressure in some individuals increases with an 
increased load of dietary salt but not in the entire population. It mocked at 
the INTERSALT trial which could not justify its hypothesis that there was a 
positive association between blood pressure and dietary salt intake. 41 
Swales J, et al in 2000 did a meta-analysis and concluded that the 
reduction of salt intake  in non-hypertensives showed very minimal changes 
of 1 to 2 mm Hg for SBP and 0.1 to 1.0 mm Hg for DBP. It suggested that 
there were various confounding factors in the trials which showed that there 
was a significant fall in blood pressure with restricted salt diet. 42 
 Fernando Elijovich, Myron H. Weinberger, Cheryl A.M. Anderson, 
et al in 2016 published a review article which defined salt sensitivity of 
blood pressure (SSBP) as a physiological  trait in humans, wherein few 
individuals of the population show variations in blood pressure with changes 
in the amount of dietary salt intake but others do not. This phenomenon is an 
inbred trait wherein salt-sensitive individuals will exhibit increase in blood 
pressure with an increased salt diet and decrease with a restricted salt diet, 
whereas the salt resistant individuals will not show any change. 43 
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MATERIALS AND  METHODS 
Study design: Cross- sectional study 
Study setting: General Medicine OPD and General Medicine Ward of Sree     
Mookambika Institute of Medical Sciences, Kulasekharam  
 Number of groups to be studied: 2 groups  
 Detailed description of the groups:  
Group A  - Non-hypertensives 
Group  B – Hypertensives ( Newly detected, with/without treatment) 
Inclusion Criteria : 
1. Willing for the study 
2. Age – 30 to 80 years 
3. Both sex 
Exclusion Criteria : 
1. Not willing 
2.  Known cases of secondary hypertension 
3. Critically ill  
4. Pregnant women and women on OCP 
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 Sample size of each group: 130 
Total sample size of the study: 260 
Scientific basis of sample size used in the study:  
     N = (1.96)2  pq    / d2           
P – Percentage of population with high sodium excretion   
P – 43 (Reference 23) 
q = 100-p 
q = 57 
d = 20% of p 
d = (20/100) *43 = 8.6 
N = (1.96)2 * 43 *57    / ( 8.6)2     = 128    
N = 130 (Rounded off ) 
Sample size of each group: 130 
Total sample size of the study: 130 * 2 = 260 
Sampling Technique:  Convenience Sampling 
Procedure (in brief): 
After acceptance of the study by the IHEC, a consent form was kept in the 
General Medicine OPD and ward. The study was explained to the patient in 
his/her local language by the principal investigator (myself) and after getting a 
written informed consent, was enrolled as a participant in this study.  
 A detailed general physical examination was performed. Basic biochemical 
investigations and participant information in the form of medical history 
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(including medication), lifestyle status (diet, exercise, smoking, alcohol status), 
socioeconomic status, blood pressure, and anthropometric measures (weight, 
height, waist and hip circumference) were entered in the case record form.  
Participant’s blood pressure was measured by a mercury 
sphygmomanometer (Diamond brand). Participants were advised to rest quietly 
for at least 5 minutes,  not to smoke, ingest food or caffeine beverages (coffee, tea 
or colas), or exercise (including stair climbing) in the previous 30 minutes prior to 
the time of measurement. In all the cases, blood pressure was recorded by taking 3 
readings, while patient was in the sitting position. BP was checked at 15 minutes 
intervals and the average of the 3 readings was taken as the final value 
Each participant was asked to provide a midstream urine sample for 
analysis.  The sample was placed in the sample processing unit and the machine 
would automatically takeup  the sample, process it and provide the result within 5 
minutes. 
Technique Used  : Ion Selective Electrode method 
Instrument Used : Beckmann’s Coulter 480, fully automatic. 
Reagent Used : 
Phosphate buffer (pH 6.5) 103 mmol/L, 
4 Amino antipyrine 0.31mmol/L. 
Phenol 5.2 m mol/L 
Cholesterol esterase > 0.2kU/L 
Cholesterol oxidase > 0.2kU/L 
Peroxidase Preservative > 10kU/L 
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Kit Used  : OSR 6116 
Parameters Studied 
 Spot Urine Sodium 
 Spot Urine Potassium 
 Spot Urine Creatinine 
 Urine Microalbumin 
 Urine Routine 
 Fasting  blood sugar (mg/dl) 
 Post prandial blood sugar (mg/dl) 
 HbA1c 
 Fasting Lipid Profile 
 Triglyceride 
 High Density Lipoprotein 
 Low Density Lipoprotein 
 Very Low Density Lipoprotein 
 Serum Urea  
 Serum Creatinine 
 Serum Uric Acid 
 Serum Sodium 
 Serum Potassium 
 Serum Protein 
 Serum Albumin 
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 Thyroid Stimulating Hormone 
 Haemoglobin 
 ESR 
 ECG 
 ECHO 
 
SAMPLE COLLECTION AND METHOD 
All the investigations were carried out in the Central Laboratory, Sree 
Mookambika Institute of Medical Sciences. 
Blood sample of not less than 5 ml was collected under aseptic 
precautions  using a sterile disposable syringe. 
 Urine samples were collected in autoclaved, dry, capped glass bottles. 
At least 10 ml of random, midstream urine samples were collected from patients.  
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FIGURE 08 : AU 480 Automated Analyser (Beckman Coulter) Used to measure 
Sr.Urea , Sr.Creatinine, Sr.Uric acid, Sr.Sodium, Sr.Potassium, Ur.Sodium, 
Ur.Potassium. 
 
FIGURE 09: AU 480 Automated Analyser Monitor showing the variables for 
analysis (Beckman Coulter) 
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FIGURE 10: Unilyte6+ Electrolyte Analyzer 
         
FIGURE 11: Urine Diluent used to dilute urine samples before placing into 
Unilyte6+ Electrolyte Analyzer. 
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Assessment of urine routine examination for protein: 
  A  sample of uncentrifuged urine, not more than 2 hours old at 
the time of testing was used by the Strip/Dipstick Method. This is a qualitative 
semi-quantitative method using Urine Reagent Strips – Urocolor 2 (Biostandard 
Diagnostics). The reagent coated strips were immersed in the urine sample, 
removed immediately and compared against the color chart given on the bottle 
label at 60 seconds after dipping. Depending upon the color chart, the presence of 
urinary protein is categorized as:  
 
    Presence of Urinary Protein  Amount in mg/dl (approx)                   
Trace < 30 mg/Dl 
                            (+) 30  – 99 mg/dL 
(++) 100 – 299 mg/dL 
(+++) 300 – 1999 mg/dL 
(++++) >2000 mg/dL 
 
Table 02: Quantification of amount of urinary protein by Dipstick test 
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FIGURE 12: Urine Reagent Strips (Dipstick Method) 
● Assessment of serum creatinine: 
  Alkaline picrate method (Modified Jaffe's Method) was used. 
Blood sample was allowed to clot and the serum was separated. 0.l ml of the same 
was mixed with 1.0 ml of Reagent R1 and Reagent R2 (manufactured by 
Beckman Coulter) and quantitative assessment of serum creatinine was obtained 
after feeding this mixture into the AU 480 automated analyzer (manufactured by 
Beckman Coulter). 
● Assessment of  blood sugar values: 
Glucose oxidase/peroxidase method  was employed. Serum or plasma, free of 
haemolysis, was used, after mixing with Reagent (manufactured by Beckman 
Coulter) and analyzed using AU 480 automated analyzer. 
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FIGURE 13: Reagent R1 and R2 for Assessment of fasting blood sugars 
 
 
● Assessment of serum uric acid values: 
 Serum uric acid levels was measured using Uricase Methodology 
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                           FIGURE 14: Reagent for serum uric acid 
 
 
Deriving 24 hour dietary intake of  sodium  and potassium : 
The 24hr urinary excretion of sodium and potassium is directly proportional to the 
24 hr dietary intake of sodium and potassium as shown in multiple studies and is 
used as a surrogate marker as estimating the dietary salt intake by recall 
methodology or questionnaires was usually biased. 23,24,25 
The 24 hr urinary excretion of sodium is not feasible to be measured as the patient 
has to be admitted and strict collection principles have to be followed. Thus, 
measuring 24hr urinary excretion of sodium and potassium for a large scale study 
becomes impossible. To overcome this hurdle, multiple equations have been 
formulated and validated.25,33,38, 
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The three widely used equations : 
1. KAWASAKI FORMULA 
       Specimen : 2nd morning urine sample 
       Predicted 24hr urine creatinine : 
       Male PrUCr24hr = (15.12*Wt)+(7.39*Ht)-(12.63*Age)-79.9 
       Female PrUCr24hr = (8.58* Wt)+(5.09*Ht)-(4.72*Age)-74.95 
24hr Urinary sodium excretion (mEq/d) : 
        XNa = ( SUNa/SUCr*10)*PrUCr24hr 
SUNa = Spot Urine Sodium 
SUCr = Spot Urine Creatinine 
24hr Urinary sodium excretion (mEq/d) =16.3√ XNa 
24hr Urinary sodium excretion (mg/d) = 23 * 24hr Urinary sodium excretion(mEq/d) 
24hr Urinary potassium excretion (mEq/d) : 
XK = (SUK / SUCr*10)*PrUCr24hr 
SUK = Spot Urine Potassium 
24hrUK (mEq/d) = 7.2√XK 
24hr Urinary potassium excretion (mg/d) = 39*24hrUK (mEq/d) 
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2. INTERSALT FORMULA 
MALE : 
23* [ ( 25.46 + 0.468 * SUNa ) – 2.75 * SUCr - 0.13 * SUK  + 4.10 * BMI + 0.26 * 
AGE  ] 
FEMALE : 
23 * [(5.07  + 0.34 * SUNa ) – 2.16 * SUCr – 0.09 * SUK + 2.39 * BMI + 2.35 * 
AGE – 0.03 * AGE  2 ] 
3. TANAKA FORMULA: 
23 * 21098 * (SUNa / SUCr * PrUCr) 0.392 
PrUCr = 14.89 * WEIGHT(kg) + 16.14 * HEIGHT(cm) – 2.04 * AGE – 2244.45 
Among the equations, the Kawasaki formula is the one most widely used in 
large trials as it takes into account the height , weight and age of the individual and 
has separate formulas for males and females. 23,24,36 
The Kawasaki formula has been validated for estimating the 24hr urinary 
sodium and potassium from random urine sample in both hypertensives and non-
hypertensives. 23,25 
Hence I have used the Kawasaki formula in the estimation of 24 hour urine 
sodium and potassium from spot urine samples. 
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STATISTICAL ANALYSIS:   
 
 Data was entered in Microsoft Excel 2013 spread sheet   
● Significant level decided before starting of study: p ≤ 0.05 –95% confidence 
level 
● Statistical tests to be used for data analysis: Mean, SD, correlation co-
efficient, chi square test, ‘t’ test. 
● Software(s) to be used for the statistical analysis: SPSS Software  Trial 
Version 20.1 
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RESULTS AND OBSERVATIONS 
 
SOCIODEMOGRAPHIC CHARACTERS 
 
SEX DISTRIBUTION 
GENDER 
 
NON HYPERTENSIVE 
 
 
Frequency
 
Percent 
 
FEMALE 67 51.5 
MALE 63 48.5 
Total 130 100.0 
 
 
TABLE 03: Sex distribution among non-hypertensives 
 
 
 
 
 
 
HYPERTENSIVE 
 
 
Frequency 
 
Percent 
FEMALE 69 53.1 
MALE 61 46.9 
Total 130 100.0 
 
TABLE 04: Sex distribution among hypertensives 
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GRAPH 01: Gender comparison among hypertensives and non-hypertensives 
 
 
 
 
The above table and graph show the gender distribution of cases in the study. Most of 
the cases studied were males. There was no statistically significant difference between 
the two groups with a p value less than 0.05  
 
 
 
 
 
 
 
 
56
58
60
62
64
66
68
70
FEMALE
MALE
gender  
non‐ HYPERTENSIVE
HYPERTENSIVE
Results 
 
	 Page	47
 
 
AGE DISTRIBUTION-NON HYPERTENSIVE 
 
 
 
                  AGE GROUP Frequeny Percent 
30-39 8 6.2 
40-49 54 41.5 
50-59 36 27.7 
60-69 27 20.8 
70-79 5 3.8 
Total 130 100.0 
 
TABLE 05: Age distribution among non-hypertensives 
 
 
 
GRAPH  02 : Age distribution among  non-hypertensives 
 
The above table and graph show the age distribution of cases in the non-hypertensive 
group. Most of the cases studied were in the age group 40-49 years among the non-
hypertensives. 
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AGE DISTRIBUTION -HYPERTENSIVE 
 
 
AGEGROUP Frequency Percent 
40-49 32 24.6 
50-59 38 29.2 
60-69 50 38.5 
70-79 10 7.7 
Total 130 100.0 
TABLE 06: Age distribution among hypertensives 
 
        
GRAPH 03: Age distribution among hypertensives 
 
 
The above table and graph show the age distribution of cases in the hypertensive 
group. Most of the cases were in the age group of 60-69 years. There was statistically 
significant difference between the two groups with a p value less than 0.05. This 
shows that as age advances the incidence of hypertension increases. 
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EDUCATION-NON HYPERTENSIVE 
 
 
EDUCATION Frequency Percent 
GRADUATE 24 18.5 
HSC 76 58.5 
POST GRADUATE 7 5.4 
POST HS DIPLOMA 10 7.7 
PRIMARY SCHOOL 13 10.0 
Total 130 100.0 
 
 
TABLE 07: Education among  non-hypertensives 
 
 
 
GRAPH 04: Education among non-hypertensives 
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EDUCATION- HYPERTENSIVE 
 
 
EDUCATION Frequency Percent 
DIPLOMA 9 6.9 
GRADUATE 27 20.8 
HSC 44 33.8 
ILLITERATE 7 5.4 
POST GRADUATE 11 8.5 
PRIMARY SCHOOL 32 24.6 
Total 130 100.0 
 
TABLE 08: Education among hypertensives 
 
 
GRAPH 05: Education among hypertensives 
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OCCUPATION - NON HYPERTENSIVE 
 
OCCUPATION Frequency Percent 
      CLERICAL 20 15.4 
FARMER 8 6.2 
PROFESSIONAL 11 8.5 
SEMI-PROFESSION 3 2.3 
SEMI-SKILLED WORKER 6 4.6 
SHOP- OWNER 6 4.6 
SKILLED WORKER 26 20.0 
UNEMPLOYED 46 35.4 
UNSKILLED WORKER 4 3.1 
Total 130 100.0 
 
TABLE 09: Occupation among non-hypertensives 
 
 
GRAPH 06: Occupation among non-hypertensives 
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OCCUPATION- HYPERTENSIVE 
 
 
OCCUPATION 
Frequency Percent 
CLERICAL 6 4.6 
FARMER 5 3.8 
PROFESSIONAL 23 17.7 
SEMI-PROFESSIONAL 11 8.5 
SEMI-SKILLED WORKER 4 3.1 
SKILLED WORKER 47 36.2 
UNEMPLOYED 34 26.2 
Total 130 100.0 
TABLE 10: Occupation among hypertensives 
 
 
 
 
GRAPH 07: Occupation among hypertensives 
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PERSONAL HABITS 
PHYSICAL ACTIVITY -NON HYPERTENSIVE 
 
 
PHYSICAL Frequency Percent 
ACTIVE 48 36.9 
HIGHLY ACTIVE 33 25.4 
INACTIVE 49 37.7 
Total 130 100.0 
 
TABLE 11: Physical activity among non-hypertensives 
 
 
 
 
GRAPH 08: Physical activity among non-hypertensives 
 
 
The above table and graph show the distribution of physical activity in the non- 
hypertensive group. The inactive cases constituted 37.7% . 
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PHYSICAL ACTIVITY - HYPERTENSIVE 
 
 
PHYSICAL Frequency Percent 
ACTIVE 76 58.5 
H.ACTIVE 17 13.1 
INACTIVE 37 28.5 
Total 130 100.0 
 
TABLE 12: Physical activity among hypertensives 
 
 
 
 
 
GRAPH 09: Physical activity among hypertensives 
 
The above table and graph show the distribution of physical activity among the cases 
in the hypertensive group. The inactive cases constituted 28 % of the group. 
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DIET-NON HYPERTENSIVE 
 
 
DIET Frequency Percent 
MIXED 106 81.5 
VEG 24 18.5 
Total 130 100.0 
 
TABLE 13: Diet among Non-hypertensives 
 
 
 
 
 
 
 
GRAPH 10: Diet among non-hypertensives 
 
 
 
The above table and graph show the distribution of dietary habits among the cases in 
the non hypertensive group. The vegetarians constituted 18.5% of cases. 
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DIET-HYPERTENSIVE 
 
 
DIET Frequency Percent 
MIXED 116 89.2 
VEG 14 10.8 
Total 130 100.0 
 
TABLE 14: Diet among hypertensives 
 
 
  
  
 
 
GRAPH 11: Diet among hypertensives 
 
 
The above table and graph show the distribution of dietary habits among the cases in 
the hypertensive group. The vegetarians constituted 10.8% of cases  
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TOBACCO USE-NON HYPERTENSIVE 
 
TOBACCO Frequency Percent 
NO 102 78.5 
YES 28 21.5 
Total 130 100.0 
TABLE 15: Tobacco use among non-hypertensives 
 
 
 
 
 
GRAPH 12: Tobacco use among non-hypertensives 
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TOBACCO USE-HYPERTENSIVE 
 
TOBACCO 
TOBACCO Frequency Percent 
NO 89 68.5 
YES 41 31.5 
Total 130 100.0 
 
TABLE 16: Tobacco use among  hypertensives 
 
 
 
 
 
 
GRAPH 13: Tobacco use among hypertensives 
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ALCOHOL ABUSE-NON HYPERTENSIVES 
 
 
ALCOHOL Frequency Percent 
NO 110 84.6 
YES 20 15.4 
Total 130 100.0 
 
TABLE 17: Alcohol abuse among non-hypertensives 
 
 
 
 
 
 
 
 
 
GRAPH 14: Alcohol abuse among non-hypertensives 
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ALCOHOL ABUSE-HYPERTENSIVE 
 
 
ALCOHOL Frequency Percent 
NO 104 80.0 
YES 26 20.0 
Total 130 100.0 
 
TABLE 15: Alcohol abuse among hypertensives 
 
 
 
 
 
 
 
GRAPH 15: Alcohol abuse among  hypertensives 
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GENERAL CHARACTERISTICS 
 
BMI-NON HYPERTENSIVES 
 
 
BMI Frequency Percent 
18.5-25 115 88.5 
25-30 15 11.5 
Total 130 100.0 
 
TABLE 19: BMI of non-hypertensives 
 
 
 
 
                             GRAPH 16 : BMI of non-hypertensives 
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BMI-HYPERTENSIVES 
 
 
BMIGROUP Frequency Percent 
18.5-25 70 53.8 
25-30 59 45.4 
30-35 1 .8 
Total 130 100.0 
 
TABLE 20: BMI of hypertensives 
 
 
 
 
 
 
Graph 17: BMI of  hypertensives 
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PULSE RATE-NON HYPERTENSIVE 
 
 
PULSEGROUP Frequency Percent 
60-69 49 37.7 
70-79 73 56.2 
80-89 8 6.2 
Total 130 100.0 
 
TABLE 21: Pulse rate among non-hypertensives 
 
 
 
 
 
 
 
GRAPH 18: Pulse rate among non-hypertensives 
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PULSE RATE-HYPERTENSIVE 
PULSE GROUP Frequency Percent 
LESS THAN 60 3 2.3 
60-69 19 14.6 
70-79 59 45.4 
80-89 33 25.4 
90-100 10 7.7 
MORE THAN 100 6 4.6 
Total 130 100.0 
TABLE 22: Pulse rate among hypertensives 
.  GRAPH 19: Pulse rate among hypertensives 
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LIPID PROFILE-NON HYPERTENSIVE 
MALE N Minimum Maximum Mean Std. Deviation
T.CHOL 63 117 206 176.16 19.230 
TGL 63 13 170 120.97 28.240 
HDL 63 32 53 39.89 4.701 
LDL 63 55 110 85.75 14.383 
VLDL 63 4 24 16.51 3.510 
FEMALE N Minimum Maximum Mean Std. Deviation
T.CHOL 67 148 210 178.99 16.646 
TGL 67 65 168 117.04 25.567 
HDL 67 28 53 38.52 5.076 
LDL 67 55 110 84.25 15.220 
VLDL 67 9 27 16.07 3.657 
LIPID PROFILE -HYPERTENSIVE 
MALE N Minimum Maximum Mean Std. Deviation 
T.CHOL 61 100 224 173.48 26.172 
TGL 61 85 230 131.08 33.233 
HDL 61 27 46 37.92 5.502 
LDL 61 58 149 107.18 20.033 
VLDL 61 11 35 21.33 7.512 
FEMALE N Minimum Maximum Mean Std. Deviation 
T.CHOL 69 89 301 160.81 35.453 
TGL 69 68 311 128.28 49.792 
HDL 69 31 61 37.61 4.177 
LDL 69 39 199 87.65 23.639 
VLDL 69 11 62 19.97 10.388 
TABLE 23: Lipid profile-  Non hypertensive and hypertensive 
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GRAPH 20: Lipid profile- non hypertensive and hypertensive 
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GENDER (NON‐HYPERTENSIVES) 
FEMALE MALE 
SBP  DBP SBP DBP
24HrUNa  0.017 ‐0.086 0.040 0.199
24HrUK  0.159  0.008 0.210 0.093
RATIO ‐0.154 ‐0.083 ‐0.154 0.044
TABLE 24: Correlation coefficient of SBP, DBP with variables among non-hypertensives 
GENDER (HYPERTENSIVES) 
FEMALE MALE 
SBP  DBP SBP DBP 
24HrUNa  ‐0.132 ‐0.046 0.348**
(0.006) 
0.381**
(0.002) 
24HrUK  0.106  0.179 0.301*
(0.018) 
0.415**
(0.001) 
RATIO  ‐0.329** 
(0.006) 
‐0.289*
(0.016) 
0.302*
(0.018) 
0.277* 
(0.031) 
TABLE 25: Correlation coefficient of SBP, DBP with variables among hypertensives 
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CORRELATION (NON‐HYPERTENSIVES) 
FEMALE<n= MALE<n= 
BMI  W:H RATIO BMI W:H RATIO
AGE  0.03 ‐0.001 0.171 ‐0.145
BMI ‐  0.348**(0.004) ‐ 0.330**(0.008)
W:H RATIO  0.348**(0.004) ‐ 0.330**(0.008) ‐
SBP  0.018 ‐0.043 0.064 0.003
DBP  0.027  0.062 0.098 0.115
FBS ‐0.052 ‐0.027 0.042 ‐0.022
T.CHOLESTEROL  0.040 ‐0.106 0.020 ‐0.0288
TGL  0.055  0.059 ‐0.107 ‐0.120
HDL  0.052 ‐0.047 ‐0.008 ‐0.141
TABLE 26: Correlation coefficient of BMI, WH Ratio with variables among  the 
non-hypertensives 
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CORRELATION (HYPERTENSIVES) 
TABLE 26: Correlation coefficient of BMI, WH Ratio with variables among   the 
hypertensives 
FEMALE MALE 
BMI  W:H RATIO BMI W:H RATIO
AGE  0.327**(0.006) 0.288*(0.016) 0.359**(0.005)  ‐0.063
BMI ‐  0.419**(0.000) ‐ 0.178
W:H RATIO  0.419**(0.000) ‐ 0.178 ‐
SBP ‐0.224  0.017 ‐0.331**(0.009)  ‐0.129
DBP  0.047 ‐0.084 ‐0.192 0.132
FBS  0.239*(0.048) 0.287*(0.017) 0.211 ‐0.189
T.CHOLESTEROL  0.099  0.182 0.207 0.228
TGL ‐0.132  0.481**(0.000) 0.160 0.303*(0.021)
HDL  0.192  0.083 ‐0.023 ‐0.222
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HYPERTENSIVE 
N Mean Std. Deviation 
BMI 130 25.1536 2.45917 
AVG SYS BP 130 147.31 15.086 
AVG DIAS BP 130 90.92 7.413 
24HrUNa(mg) 130 6343.046876 2362.7289858 
24HrUK(mg) 130 2291.613872 534.9343299 
24HrUNa/24HrUK (ratio) 130 2.725597 0.5944001 
TABLE 28: Comparison of BMI, BP and Urine electrolytes among  hypertensives 
 NON HYPERTENSIVE 
Descriptive Statistics 
N Mean Std. Deviation 
BMI 130 22.7425 2.12617 
AVG SYS BP 130 117.62 9.048 
AVG DIAS BP 130 72.15 6.931 
24HrUNa(mg) 130 5131.489091 1013.6512193 
24HrUK(mg) 130 2100.723358 476.4711547 
24HrUNa/24HrUK (ratio) 130 2.514944 0.5462737 
TABLE 29: Comparison of BMI, BP and Urine electrolytes among non-hypertensives 
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GRAPH 21: Comparison of BMI, blood pressure and Urine electrolytes among 
hypertensives and non-hypertensives 
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Chi-square test is used to find out the association between age, blood pressure with 24 
hour urine excretion of sodium (gm) in hypertensive and non-hypertensive patients. p 
value less than 0.05 is considered as significant. 
(24hrUNa) Non hypertensive (24hrUNa) Hypertensive 
Chi square value p value Chi square valu p value 
Age 5.764 0.215 16.159 0.013*
SBP 1.330 0.249 9.674 0.046*
DBP 1.039 0.308 24.041 0.000**
(* represents p value less than 0.05, ** represents p value less than 0.01) 
TABLE 30: Associaion between age, blood pressure with 24 hour urine excretion of 
sodium among hypertensives and non-hypertensives
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t’ test used to compare the mean BMI, systolic blood pressure, diastolic blood 
pressure, 24 hour urine excretion of sodium, 24 hour urine excretion of potassium, 
and their ratio between hypertensive and non-hypertensive patients. p value less than 
0.05 is considered as significant. 
TABLE 31: t value comparison  
In our study for all variables ‘p’ values are less than 0.05. So the mean difference of 
the above variables is significant between hypertensive and non-hypertensive patients 
(** represents p value less than 0.01). 
t-value p-value
BMI 8.456 0.000**
SBP 19.245 0.000**
DBP 21.087 0.000**
24HrUNa 5.373 0.000**
24HrUK 3.038 0.003**
24HrUNa/24HrUK 2.975 0.003**
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DISCUSSION 
The total number of subjects included in this study was 260. 
Among these 260 subjects, 130 were hypertensive and 130 were non-
hypertensive. 
In my study the age of study population varies from 30 to 79 
years. Among non hypertensives the maximum frequency of patients 
were in the range of 40-49yrs whereas among the hypertensives the 
maximum frequency was in the range of 60-69yrs.  
In normotensive group, 51.5% constituted females and 48.5% 
males. In the hypertensive group 53.1% constituted females and 46.9% 
males. Hence there was an almost even distribution of sexes in this 
study population.  
The average systolic blood pressure among the non-
hypertensives was 117.6 ± 9.05 and average diastolic blood pressure 
was 72.15 ± 6.93. The average systolic blood pressure among the 
hypertensives was 143.3 ± 15.1 and average diastolic blood pressure 
was 90.92 ± 7.41. 
In my study, the average urinary sodium excretion in 24 hrs 
among non-hypertensives was 5131.49 ± 1013.65 mg/d and among 
hypertensives was 6343.05 ± 2362.73 mg/d.  
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The average urinary potassium excretion in 24 hrs among the              
non-hypertensives was 2100.72 ± 476.47 mg/d and among 
hypertensives was 2291.61 ± 534.93 mg/d. 
The mean ratio of 24 hr urinary excretion of sodium to 24 hr 
urinary excretion of potassium was 2.51 ± 0.55 in the non-hypertensive 
group and 2.72 ± 0.59 mg/d in the hypertensive group. 
Andrew Mente, Martin J.O’Donnell, et al in 2014 conducted the 
PURE study (Prospective Urban Rural Epidemiology), a multi-centric 
trial with 102,216 participants from various countries including India. 
The average 24 hr sodium excretion per day was 4930 ± 1726 mg/d 
and the average 24 hr potassium excretion per day was 2120 ± 601 
mg/d. The average Systolic Bp was 131.7 ± 21.5 mm Hg and the 
average Diastolic Bp was 81.9 ± 12.2 mm Hg 23 
Park J, Kwock ,et al did a meta analysis in 2016 among the 
Korean population to find the relation of urinary sodium to potassium 
ratio with blood pressure .The average daily urine sodium excretion 
was 4533.17 ± 30.24 mg/d, the average daily urine potassium excretion 
was 3104.64 ± 15.97 mg/d and the average ratio of daily urine sodium 
to potassium was 1.54 ± 0.01 33
The average daily urine sodium excretion was higher in our 
study when compared to the other two above mentioned well validated 
studies possibly indicating the higher dietary salt intake in our 
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population. It is to be noted that the average daily sodium intake 
among the non-hypertensives of our population is still higher than the 
average of the other studies. 
Among non-hypertensives, 58.5 % were high school certified 
whereas in the hypertensive population 33.8% were high school 
certified. High school certification had the maximum prevalence 
among both the groups. Education was found to have no significant 
relation with dietary intake of sodium and potassium in our study.  
In my study, among the non-hypertensives 81% of individuals 
took a mixed diet while 18.5% took a vegetarian diet only while in the 
hypertensive group 89.2% took a mixed diet and 10.8% a vegetarian 
diet. No significance was found between blood pressure increase and 
mixed or vegetarian diet. 
The prevalence of tobacco abuse was found to be more among 
the hypertensives (31.5%) than in the non-hypertensives (21.5%). 
Alcohol abuse was also found to be more among the hypertensives 
(20%) when compared to the non hypertensives (15.4%). It is thus 
observed that the there is a higher prevalence of elevated blood 
pressures among alcohol and tobacco abusers. 
In my study, a statistically significant correlation was seen 
between the BMI and waist –hip ratio in both males (p-0.008) and 
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females (p-0.004) in the non hypertensive group and females in the 
hypertensive group (p-0.000). 
In the non hypertensive group, the average BMI was 22.74 ± 
2.13 with the majority of individuals in the normal range of BMI 
(88.5%) with the remaining coming under the overweight category 
(11.5%). In contrast, among  hypertensives the average BMI was 25.15 
± 2.46 with only 53.8%  within the normal range and 45.4% in the 
overweight category and 8% in the obese class I category. Thus it is 
evident that the prevalence of hypertension is higher with the 
increasing BMI.  
Jay.S.Kaufman, Michael.C.Asuzu, et al in their study which 
investigated 11,235 adults from Africa concluded that there was a 
positive correlation between blood pressure and the BMI 45  
Mohan V, Pradeepa R, Premalatha G et al in 2003 in Chennai 
did an epidemiological study – Chennai Urban Population Study 
(CUPS) among 1262 individuals. They demonstrated a similar 
significant relation between BMI, obesity, waist –hip ratio and 
cardiovascular disease 28 
Among the male hypertensives, there was a significant positive 
correlation between both systolic Bp (p-0.006) and diastolic Bp (p-
0.002) and 24hr urinary sodium. In the same group, there was a 
significant association of 24 hr urinary excretion of potassium and both 
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systolic Bp (p-0.018) and diastolic Bp (p-0.001). A positive association 
was also established between ratio of urinary sodium to potassium to 
both systolic Bp (p-0.018) and diastolic Bp (p-0.031). 
In Andrew Mente, Martin J.O’Donnell,et al trial, they 
concluded that there was a non-linear association in the excretion of 
urinary sodium and potassium with blood pressure and was significant 
especially in individuals known to be hypertensive, elderly population 
and people binging on high sodium diets 23 
In the Korean study by Kwock CK, et al in 2016, the association  
of sodium to potassium ratio on blood pressure was evaluated and it 
stated that higher the urinary sodium to potassium ratio, greater the 
blood pressure and prevalence of hypertension and its adverse 
cardiovascular  effects 33
In my study, a statistically significant correlation was seen 
between the BMI and waist –hip ratio in both males (p-0.008) and 
females (p-0.004) in the non hypertensive group and females in the 
hypertensive group (p-0.000). 
The chi square test shows a strong association between the 24 hr 
urinary excretion of sodium (surrogate for 24hr dietary intake of 
sodium) and systolic (p-0.046) and diastolic (p-0.000) blood pressure 
in the hypertensive group. A similar association was not seen in the 
non-hypertensive group.  
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Leenan F, Whitmore,et al in 1999 in Canada recommended that 
sodium reduction was not warranted in the individuals with a normal 
blood pressure and salt restriction of 3-7gm /d was adviced only for the 
hypertensives 30 
The t-test comparing hypertensives and non hypertensives with 
other variables showed a significant variation among the hypertensives 
and non-hypertensives with regard to BMI, systolic Bp, diastolic Bp, 
24 hr Urine sodium, 24 hr Urine potassium and the ratio of daily Urine 
sodium to potassium. These results are similar to the Chennai Urban 
Population Study (CUPS) by Shanthirani CS, et al 28 
The estimated daily dietary intake of sodium and potassium was 
high in both the hypertensives and non-hypertensives when compared 
to other studies.23,33 There was a positive correlation between the daily 
urinary sodium and potassium and its ratio with both systolic and 
diastolic Bp among the hypertensives. The daily urine sodium and 
potassium had no significant association with blood pressure in the 
non-hypertensives. Thus, the alternate hypothesis of this study is 
scientifically proved to be true. 
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CONCLUSION 
 There is a positive association between 24hr urine sodium and potassium
(surrogate for 24 hr dietary sodium and potassium ) and both systolic and
diastolic blood pressure among hypertensives.
 There is a significant relation between ratio of 24hr urine sodium to
potassium and both systolic and diastolic blood pressure among the
hypertensives.
 The estimated daily dietary intake of sodium and potassium in our study is
higher in both the hypertensives and non-hypertensives when compared to
various other studies.
 There is a statistically significant positive correlation between BMI and
Waist – Hip ratio among both males and females in the normotensives.
 Dietary salt reduction should be recommended to all hypertensives to reduce
the risk of further cardiovascular complications.
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LIMITATIONS 
 The dietary sodium and potassium values obtained are estimated and
not measured.
 All biochemical tests were carried out only once and hence day to day
variability could not be accounted.
 When compared to other studies the sample size was small.
 Being a hospital based study, the participants may not represent the
actual picture in the general population.
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SUMMARY 
Lifestyle changes and daily stress have lead to the increase in the 
global incidence of hypertension. Among the non-communicable diseases, 
cardiovascular morbidity and mortality holds the major proportion which is 
attributed to the increase in incidence of hypertension. Restricting dietary salt 
has emerged as one of the major modifiable risk factors in the control of 
hypertension. Estimating the dietary intake of salt is thus important to the 
clinician in order to further manage the individual regarding his/her blood 
pressure control, modification in the dietary allowance, stratifying the risk of 
further developing cardiovascular and other complications and its optimal 
management. 
The study was a hospital based cross sectional study conducted in Sree 
Mookambika Institute of Medical Sciences, Kulasekharam, KanyaKumari 
district. 
The total number of subjects included in this study was 260. Among 
those 260 subjects, 130 were hypertensive and 130 were non-hypertensive. In 
my study the age of study population varies from 30 to 79 years. In the non-
hypertensive group, 51.5% constituted females and 48.5% males. In the 
hypertensive group, 53.1% constituted females and 46.9 % males. Hence 
there was an almost even distribution of sexes in this study population.  
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The average systolic blood pressure among the non-hypertensives was 
117.6 ± 9.05 and average diastolic blood pressure was 72.15 ± 6.93. The 
average systolic blood pressure among the hypertensives was 143.3 ± 15.1 
and average diastolic blood pressure was 90.92 ± 7.41. 
The average urinary sodium excretion in 24 hrs among non- 
hypertensives was 5131.49 ± 1013.65 mg/d and among hypertensives was 
6343.05 ± 2362.73 mg/d. The average urinary potassium excretion in 24 hrs 
among the non-hypertensives was 2100.72 ± 476.47 mg/d and among 
hypertensives was 2291.61 ± 534.93 mg/d. The mean ratio of 24 hr urinary 
excretion of sodium to 24 hr urinary excretion of potassium was 2.51 ± 0.55 
in the non-hypertensive group and 2.72 ± 0.59 mg/d in the hypertensive 
group. 
The average daily urine sodium excretion was higher in our study 
when compared to other large scale studies possibly indicating the higher 
dietary salt intake in our population . It is noted that the average daily sodium 
intake among even the non-hypertensives of our population is still higher than 
the average of other studies. 
The prevalence of tobacco abuse was found to be more among the 
hypertensives (31.5%) than in the non-hypertensives (21.5%). Alcohol abuse 
was also found to be more among the hypertensives (20%) when compared to 
the non-hypertensives(15.4%). It is thus observed that the there is a higher 
prevalence of elevated blood pressures among alcohol and tobacco abusers. 
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A statistically significant correlation was seen between the BMI and 
waist –hip ratio in both males and females in the non-hypertensive group and 
females in the hypertensive group. 
In the non-hypertensive group, the average BMI was 22.74 ± 2.13 with 
the majority of individuals in the normal range of BMI (88.5%) and others  in 
the overweight category ( 11.5%). Among hypertensives, the average BMI 
was 25.15 ± 2.46 with only 53.8%  within the normal range and 45.4% in the 
overweight category and 8% in the obese class I category. Thus it is evident 
that the prevalence of hypertension is higher with increasing BMI. A 
significant correlation was seen between the BMI and waist –hip ratio in both 
males and females in the non hypertensive group and females in the 
hypertensive group. 
Among the male hypertensives, there was a significant positive 
correlation between both systolic Bp and diastolic Bp and 24hr urinary 
sodium, 24 hr urinary excretion of potassium and ratio of 24 hr urinary 
sodium to potassium. A strong association was seen between the 24 hr urinary 
excretion of sodium (surrogate for 24hr dietary intake of sodium) and systolic 
and diastolic blood pressure in the hypertensive group. A similar association 
was not seen in the non-hypertensive group.  
When comparing hypertensives and non-hypertensives with other 
variables a significant variation was seen with regard to BMI, systolic Bp, 
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diastolic Bp, 24 hr Urine sodium, 24 hr Urine potassium and the ratio of daily 
Urine sodium to potassium. 
The estimated daily dietary intake of sodium and potassium was high 
in both the hypertensives and non-hypertensives when compared to other 
studies.  There was a positive correlation between the daily urinary sodium 
and potassium and its ratio with both systolic and diastolic Bp among the 
hypertensives. The daily urine sodium and potassium had no significant 
association with blood pressure in the non-hypertensives.  
The high prevalence of cardiovascular diseases and their early 
incidence in our population could well be attributed to the high salt diet in our 
society. Large scale randomized controlled trials are necessary to followup 
these patients to understand the safe and permissible levels of daily salt intake 
in our diet. Urinary sodium and potassium and their ratio in particular could 
well be developed into a risk stratification tool to screen patients thereby 
preventing and delaying if not stopping the pandemic of hypertension and its 
cardiovascular morbity and mortality. 
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ANNEXURE – I 
ANNEXURE - II 
LIST OF ABBREVIATIONS USED 
HbA1c - Glycosylated haemoglobin 
DM                 - Diabetes Mellitus 
BMI - Body mass index 
VLDL - Very low density lipoprotein 
HDL - High density lipoprotein 
LDL - Low density lipoprotein 
FBS - Fasting blood sugar 
PPBS               - Post Prandial blood sugar 
RBS - Random blood sugar 
UA - Uric acid 
JNC  - Joint National Committee        
SBP     - Systolic Blood Pressure 
DBP  - Diastolic blood pressure 
HTN   -  Hypertension 
YRS - Years 
SUM               -        Spot Urine Method     
FCM               -         Food Consumption Method 
SUNa               -        Spot Urine Sodium 
SUK -       Spot Urine Potassium 
SUCr -       Spot Urine Creatinine 
CV  -       Cardio Vascular 
ESH               -       European Society of Hypertension 
ESC               -       European Society of Cardiology 
ACC              -       American College of Cardiology 
AHA             -        American Heart Association 
ASH              -        American Society of Hypertension 
ADA             -        American Diabetic Association 
CDA             -        Canadian Diabetic Association 
ISH                -       International Society of Hypertension 
TOD              -       Target Organ Damage 
ACC              -       Accompanying Clinical Condition 
DASH           -       Dietary Approaches to Stop Hypertension 
NaCl             -        Sodium Chloride 
CURES        -        Chennai Urban Rural Epidemiology Study 
ANNEXURE - III 
CONSENT FORM 
PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Volunteers, 
      We welcome you and thank you for your keen interest in participating in this research 
project. Before you participate in this study, it is important for you to understand why this 
research is being carried out. This form will provide you all the relevant details of this research. 
It will explain the nature, the purpose, the benefits, the risks, the discomfort, the precautions and 
the information about how this project will be carried out. It is important that you can read and 
understand the contents of the form carefully. This form may contain certain scientific terms and 
hence, if you have any doubts or if you want more information, you are to ask the study 
personnel or the contact person mentioned below before you give your consent and also at any 
time during the entire course of the project. 
1. Name of the Principal Investigator:  Dr. Shahbaz Zailu M
Postgraduate – M.D General Medicine 
Sree Mookambika Institute of Medical Sciences, 
Kulasekharam 
2. Name of the Guide: Dr. R.Mohandhas 
   Professor  
   Department of General Medicine 
SreeMookambika Institute of Medical Sciences, 
Kulasekharam 
3. Name of Co-guide:    Dr. V. Rajendran 
   Professor  
   Department of General Medicine 
SreeMookambika Institute of Medical Sciences, 
Kulasekharam  
4. Institute: details with Address:    SreeMookambika Institute of Medical 
               Sciences, Kulasekharam 
   Kanyakumari District 
   Tamil Nadu-629161 
5. Title of the study:
ASSOCIATION OF DIETARY SODIUM AND POTASSIUM WITH BLOOD 
PRESSURE IN A TERTIARY CARE CENTRE 
6. Background Information:
Hypertension is today’s number one silent killer all over the world. Hypertension is 
reported to be the fourth contributor to premature death in developed countries and the 
seventh in developing countries 
There is a continuous relationship between the level of blood pressure and the risk of 
CV complications. Starting at 115/75 mmHg, CVD risk doubles with each increment of 20/10 
mm Hg throughout the blood pressure range. There is evidence that the risk of cardiovascular 
events in Asian Indians is higher at relatively lower levels of blood pressure.  
The prevalence of hypertension in the last six decades has increased from 2% to 25% 
among urban adults and from 2% to 15% among the rural adults in India and the prevalence 
rates of coronary artery disease and stroke have more than tripled. Hypertension awareness, 
treatment and control status in our country is low. It has been seen that only one in five 
persons is on treatment and less than 5% are controlled. Preventive measures are required so 
as to reduce obesity, increasing physical activity, decreasing the salt intake of the population 
and a concerted effort to promote awareness about hypertension and related risk behaviors.  
Effective population-based interventions are required to reduce the global burden of 
cardiovascular disease (CVD). Reducing salt intake has emerged as a leading target, with 
many guidelines including the World Heart Organization (WHO) in 2003, recommending that 
adults ingest <2.0 g/day of sodium (which corresponds to 5 g of salt/day). However, there 
have been a number of studies that have questioned whether the recommended target of 
sodium intake is optimal, with some recent studies reporting that intakes of under 3 g/day may 
be associated with an increased risk of CV death. 
  Thus, despite a large number of studies evaluating the association between 
sodium intake and blood pressure and CVD there remains a controversy surrounding the 
optimal target for dietary sodium intake.  
7. Aims and Objectives:
To find out the association of dietary intake of sodium and potassium as estimated from 
the urinary excretion of these cations and their relation with blood pressure. 
8. Scientific Justification of the study:
In this era of modern medicine, NCDs form the major cause of morbidity and mortality. 
The largest proportion of NCD deaths is caused by cardiovascular diseases. Over the years, 
studies have shown a continuous linear relationship between high sodium intake and the risk 
of cardiovascular disease. These results are yet insufficient to conclude whether low sodium 
intake is associated with an increased or reduced risk of cardiovascular disease in the general 
population.  
Recently, few studies have also shown that a low salt intake may be associated with 
adverse health effects in some subgroups, especially patients with heart failure or other forms 
of cardiovascular disease, diabetes, or chronic kidney disease. Thus, there are inconsistencies 
whether a low sodium diet decreases the CV risk among the normal population and 
hypertensives or in the contrary is actually deleterious. 
The association of dietary sodium and potassium with blood pressure is thus a very 
interesting and controversial topic. There are very few Indian studies from Chennai regarding 
the subject. The dietary intake of sodium and potassium and its relation to blood pressure and 
other parameters among the population visiting our tertiary care centre SMIMS, 
Kulasekharam would make a good study. 
In this dissertation, I have proposed to estimate the dietary intake of sodium and 
potassium from the urinary excretion of these cations and compare it with the blood pressure 
of normotensives and hypertensives . 
9. Procedure of the study:
After acceptance of the study by the IHEC, a consent form will be kept in the General 
Medicine OPD and ward. The study would be explained to the patient in his/her local 
language by the principal investigator and after getting a written informed consent, would be 
enrolled as a participant in this study.  
 A detailed general physical examination would be performed.Basic biochemical 
investigations and participant information in the form of medical history (including 
medication), lifestyle status (diet, exercise, smoking status), socioeconomic status, blood 
pressure, and anthropometric measures (weight, height, waist and hip circumference) would 
be entered in the case record form.  
Participant’s blood pressure would be measured by a mercury sphygmomanometer. 
Participants would be advised to rest quietly for at least 5 minutes,  not to smoke, ingest food 
or caffeine beverages (coffee, tea or colas), or exercise (including stair climbing) in the 
previous 30 minutes prior to the time of measurement. 
Each participant will provide one midstream urine samples for analysis.  The sample 
would be placed in the sample processing unit and the machine will automatically take this 
sample, process it and provide the result within 5 minutes. 
10. Expected risk of the participants: No risk
11. Expected Benefits of the Research for the participants:
To decrease the risk of cardiovascular and other comorbidities and mortality  by 
intensive counseling and dietary modification and thereby intervening a modifiable risk factor 
- blood pressure. 
12. Maintenance of confidentiality: All data collected for the study will be kept
confidentially and would reflect on general statistical evaluation only and would not reveal 
any personal details 
13.       Why have I been chosen to be in this study: You fulfil the criteria of selection
14. How many people will be in the study: 260
15. Agreement of compensation to the participants: No
16. Anticipated prorated payment, if any, to the participants of the study: Nil
17. Can I withdraw from study at any time during the study period: Yes
18. If there is any new finding/information, would I be informed: Yes
19. Expected duration of the participants participation in the study:  One visit
20. Any other pertinent information: No
21. Whom do I contact for further information: Dr. Shahbaz Zailu M
Place:        
Date:   
Signature of Principal Investigator  
             Signatre of Participant 
For any study related queries, you are free to contact 
Dr. Shahbaz Zailu M 
Post Graduate – M.D General Medicine 
Department of General Medicine 
Sree Mookambika Institute of Medical Sciences, 
Kulasekharam 
Mobile number: 00091 8281027768 
e-mail: shahbaz.zailu@gmail.com 
CONSENT FORM 
PART 2 OF 2 
TITLE OF THE PROJECT: Association of dietary sodium and potassium with blood pressure 
in a tertiary care centre 
PARTICIPANTS NAME: 
ADDRESS: 
The details of the study have been provided to me in writing and explained to me in my 
own language. I confirm that I understood the above study and had the opportunity to ask 
questions, I understand that my participation in this study is voluntary and that I am free to 
withdraw at any time. Withdraw at any time, without giving any reason, without the medical care 
that will be normally be provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for scientific purpose. I 
have been given an information sheet giving details of this study. I fully consent to participate in 
the above study. 
( I also consent/ do not consent to use my stored biological samples for future scientific 
purposes: Yes/No – if Applicable) 
Signature of the Participant:  Date: 
Signature of Witness:  Date: 
Name and Address of Witness: 
Signature of the Investigator:  Date: 
ANNEXURE - IV 
ASSOCIATION OF DIETARY SODIUM AND POTASSIUM WITH BLOOD PRESSURE IN 
A TERTIARY CARE CENTRE 
PROFORMA 
PARTICIPANT NUMBER  : 
GROUP  A     NON HYPERTENSIVE  __ 
GROUP  B     HYPERTENSIVE         __  (KNOWN / NEWLY DETECTED) 
OP/ IP NUMBER  : 
NAME  : 
AGE  :                 GENDER  : 
EDUCATION STATUS  : 
OCCUPATION  : 
FAMILY INCOME PER MONTH     : 
LEVEL OF PHYSICAL ACTIVITY  : 
INACTIVE/ LOW 
ACTIVE 
HIGHLY ACTIVE 
TOBACCO USE     
NEVER   /    FORMER   /    CURRENT       
PACK YEARS:   ______ 
ALCOHOL CONSUMPTION 
NEVER   /    FORMER   /    CURRENT 
DIET        
MEDICATION  H/O PAST 1 MONTH : 
FAMILY HISTORY : 
CO MORBIDITIES:                                        DURATION         MEDICATION                     
1.HYPERTENSION`       
2.DIABETES MELLITUS 
3.DYSLIPIDEMIA 
4.CORONARY ARTERY DISEASE 
5.CONGESTIVE HEART FAILURE 
6.CEREBROVASCULAR ACCIDENT 
7.PERIPH  OBSTR VASCULAR DISEASE 
ANTHROPOMETRY 
 WEIGHT      _______ kg           
 HEIGHT       _______ cm                                          BMI  _____  kg/m2 
WAIST CIRCUMFERENCE ____   cm 
 HIP CIRCUMFERENCE       ____   cm                      WHR _____ 
BLOOD PRESSURE                                                                     
                 SUPINE                                _________ mm Hg       
                 SITTING                              __________mm Hg       
                 STANDING                           _________mm Hg      
 
PLUSE    SUPINE                                 _________ /min           
                 SITTING                                _________/min             
                 STANDING                           _________/min        
CLINICAL EXAMINATION 
PALLOR                                            :                        ICTERUS           : 
CYANOSIS                                        :                       CLUBBING        : 
 
LYMPHNODE ENLARGEMENT    :                    PEDAL EDEMA   : 
 JVP                                                    :                     RENAL  BRUIT   : 
CVS   : 
RS      : 
P/A     : 
CNS   : 
LABORATORY DATA 
HAEMOGLOBIN   :                      
ESR                                           :                                    
FASTING LIPID PROFILE 
    TOTAL CHOLESTEROL     :                          HDL          :  
    TRIGLYCERIDE               :                           VLDL       : 
    LDL        :   
FASTING BLOOD SUGAR (FBS)           : 
POST PRANDIAL BLOOD SUGAR (PPBS)     : 
HBA1C                       : 
SERUM UREA                       : 
SERUM CREATININE                       :  
SERUM URIC ACID                      : 
SERUM SODIUM                               : 
SERUM POTASSIUM                               : 
 
SERUM PROTEIN                                      : 
SERUM ALBUMIN                                  : 
URINE ROUTINE 
     ALBUMIN            :                     PUS CELLS            : 
     SUGAR   :                      BACTERIA             : 
     RBC                   :                      CASTS                    :  
                                                                                               URINE 
SODIUM     : 
URINE POTASSIUM    : 
URINE CREATININE    : 
URINE MICROALBUMINURIA  : 
TSH                : 
ECG                                                       :      
 
ECHO                      : 
 
